PUBLICATIONS

Through its publications, INSS aims to provide expert insights, cutting-edge research, and innovative solutions that contribute to shaping the national security discourse and preparing the next generation of leaders in the field.

 

Publications

Results:
Category: Center for the Study of WMD

April 30, 2025

INSS Participates in Proliferation Security Initiative (PSI) Balkans Regional Engagement in Slovenia

On 15 April, Mr. Paul J. David-Justus and Senior Policy Fellow Dr. Kathleen Ellis facilitated a tabletop exercise at the Proliferation Security Initiative (PSI) Balkans Regional Engagement in Ljubljana, Slovenia.

Feb. 19, 2025

Drones and Biotechnological Weaponry: Emerging Risks, Strategic Threats, and Viable Readiness

Dr. Diane DiEuliis (CSWMD), in collaboration with Dr. James Giordano (CDTFW) from INSS, delve into the formidable challenge posed by the convergence of drone technology, synthetic biology, and gene-editing.

Oct. 7, 2024

Thirty Years of the Center for the Study of Weapons of Mass Destruction

NDU’s Center for the Study of Weapons of Mass Destruction (CSWMD), part of the Institute for National Strategic Studies, has been a trusted resource on WMD challenges to senior Defense and other interagency policy leaders for 30 years.

Sept. 23, 2024

China's Theater-Range, Dual-Capable Delivery Systems: Integrated Deterrence and Risk Reduction Approaches to Counter a Growing Threat

China has engaged in a dramatic buildup of its nuclear forces over the past decade. While much of the attention on China’s new nuclear arsenal has focused on its development and expansion of its strategic nuclear triad, this growth has also included significant numbers of theater-range, dual-capable delivery systems. These forces are not capable of reaching the U.S. mainland but can range U.S. and allied forces and bases across strategically significant swathes of the Indo-Pacific.

Feb. 16, 2023

Private-Sector Research Could Pose a Pandemic Risk. Here’s What to do About It

In 2018, Canadian academics with pharmaceutical industry funding made a stunning announcement. They had synthesized horsepox, a pathogen that no longer exists in nature and that is closely related to the smallpox virus, variola. The controversial product was meant as a vaccine candidate—intended to infect humans and confer immunity without being